Mainz Biomed N.V (NASDAQ:MYNZ) has a beta value of 0.08 and has seen 3.39 million shares traded in the last trading session. The company, currently valued at $4.61M, closed the last trade at $0.23 per share which meant it lost -$0.02 on the day or -7.31% during that session. The MYNZ stock price is -1373.91% off its 52-week high price of $3.39 and 17.39% above the 52-week low of $0.19. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.54 million shares traded. The 3-month trading volume is 2.08 million shares.
Mainz Biomed N.V (NASDAQ:MYNZ) trade information
Sporting -7.31% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MYNZ stock price touched $0.23 or saw a rise of 19.83%. Year-to-date, Mainz Biomed N.V shares have moved -80.42%, while the 5-day performance has seen it change -12.32%. Over the past 30 days, the shares of Mainz Biomed N.V (NASDAQ:MYNZ) have changed -11.43%. Short interest in the company has seen 1.7 million shares shorted with days to cover at 0.66.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V (MYNZ) estimates and forecasts
Figures show that Mainz Biomed N.V shares have outperformed across the wider relevant industry. The company’s shares have lost -69.17% over the past 6 months, with this year growth rate of 45.68%, compared to 17.50% for the industry. Revenue growth from the last financial year stood is estimated to be 34.10%.
2 analysts offering their estimates for the company have set an average revenue estimate of 220k for the current quarter. 2 have an estimated revenue figure of 300k for the next ending quarter.
MYNZ Dividends
Mainz Biomed N.V is expected to release its next earnings report on 2024-Jul-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Mainz Biomed N.V (NASDAQ:MYNZ)’s Major holders
The top two institutional holders are NORTHERN TRUST CORP with over 29934.0 shares worth more than $12004.0. As of 2024-06-30, NORTHERN TRUST CORP held 0.1414% of shares outstanding.
The other major institutional holder is VONTOBEL HOLDING LTD., with the holding of over 25000.0 shares as of 2024-06-30. The firm’s total holdings are worth over $10025.0 and represent 0.1181% of shares outstanding.
